Its a full detailed slide for your presentation.

2. The challenges of new technology

3. The challenges of new technology

4. Product safety - the lessons of history

5. The challenges of nanotechnology
 Spectacular promises, benefits for all
 ...but at what price?
 these questions arising in a world in which consumers are
increasingly intolerant to risk

6. D R M A R I O N P A L M E R
S E N I O R S C I E N T I S T
L O V E L L S S C I E N C E U N I T
Nanotechnology

7. Definition
 Most widely used definition:
 Nanoscience is the study of phenomena and manipulation of
materials at atomic, molecular and macromolecular scales,
where properties differ significantly from those at a larger
scale.
 Nanotechnologies are the design, characterisation,
production and application of structures, devices and systems
by controlling shape and size at nanometre scale.

8. Millimetre scale (1 m = 1000 mm)
ant and flea
 5 mm
 3mm
 1mm
http://www.nation
alinsectweek.co.u
k/resources/buzz
_ant_06.pdf
www.nanotec.org.uk/report/chapter2.pdf
http://commons.wiki
media.org/wiki/File:D
rosophila_melanoga
ster_-
_front_(aka).jpg

9. Micrometre scale (1 mm = 1000 µm)
eye of a fruit fly and a red blood cell
 400 µm
 8 µm
http://www.molbio1.princeton.edu/facility/confocal/sem/imagelist1.html
www.mta.ca/dmf/blood.htm

10. Nanometre scale (1 µm = 1000 nm) – viruses & DNA
 50 – 100 nm  2 nm
http://www.gala-instrumente.de/images/deben_CCD_DNA.jpg
www.answers.com/topic/virus

11. Nanostructures
 Nanoparticles

12. Nanostructures
 Fullerenes – e.g. carbon nanotubes and buckyballs

13. Nanostructures
 Quantum dots
http://www.nist.gov/public_affairs/update/quantumdots.htm
http://www.nanopicoftheday.org/2003Pics/QDRainbow.htm

14. Nanostructures
 Non-carbon nanotubes
 Nanowires
 Biopolymers
 Dendrimers
http://nano.med.umich.edu/projects/dendrimers.html
http://www.nist.gov/public_affairs/05nano_image_gallery.htm

15. Nanotechnology
What make technology at the
nanoscale different from
technology at the macroscale?

16. Volume to surface area ratio
 As objects get smaller
they have a much
greater surface area
to volume ratio
2 cm cube has
a surface area
of 24 cm2 and a
volume of 8 cm3
(ratio = 3:1)
10 cm cube has a
surface area of 600
cm2 and a volume of
1000 cm3 (ratio =
0.6:1)

17. Physical properties
 At very small sizes physical properties (magnetic,
electric and optical) of materials can change
dramatically.
http://www.omicron.de/index2.html?/re
sults/spin_polarized_tunneling_induce
d_luminescence_microcopy_sp_tilm/in
dex.html~Omicron

18. Applications
 Antibacterial effect of silver
www.nanotech-now.com

19. Applications
 Coatings - self-cleaning windows and stainproof
clothing

20. Applications
 Microchips
•http://ion.asu.edu/cool66_IC2/cool66_ic_thumb.htm

21. Applications
 Sunscreens and cosmetics

22. Applications
 Catalysts
 Envirox™ cerium oxide
 Nanoremediation
 SAMMS technology to remove
mercury
 Paper
 photographic paper
 Filters
 nanofibres
 Toothpaste
 to remineralise teeth
 Food
 packaging
 Paint
 improved adhesion and anti-
fungal qualities/anti-graffiti
 Clothes
 non-staining and anti-radiation
 Batteries
 (Black & Decker) phosphate
nanocrystal technology
 Cleaning products

23. Why is there so much interest/concern about
nanotechnology?
 Enormous potential
 Huge gaps in knowledge concerning the possible
risks
 Difficulty in detecting and removing
 Absence of regulation

24. Potentials risks associated with nanotechnology
 Adverse health effects in humans from deliberate or
accidental exposure
 Adverse effects on the environment from deliberate or
accidental exposure
 Potentially explosive properties of nanostructures
 “Grey goo”

25. Risk assessment problems
 Very difficult to detect without sophisticated equipment
 Difficult to predict how particles will behave in the environment
(dispersed/clumped)
 Small size may result in particles passing into the body more easily
(inhalation, ingestion, absorption)
 May be more reactive due to surface area to volume ratio
 Potential to adsorb toxic chemicals
 Persistence - Longevity of particles in the environment and body are
unknown

26. Toxicological difficulties
 All structures are likely to have a unique toxicological
profile
 Standardised terminology agreed recently
 Particle size may be less important than the surface
characteristics of the material
 Standard dose-response tests may not be appropriate

27. Carbon nanotubes
http://www.nano-lab.com/nanotube-image.html

28. Carbon Nanotubes
 Commercially produced by companies such as
Thomas Swan
 Desirable product
http://www.tennis.com/yo
urgame/gear/racquets/babo
lat/babolat.aspx?id=56932

29. Potential applications of carbon nanotubes
Materials & Chemistry
- Ceramic and metallic CNT composites
- Polymer CNT composites (heat
conducting polymers)
- Coatings (e.g. conductive surfaces)
- Membranes and catalysis
- Tips of Scanning Probe Microscopes
(SPM)
Medicine & Life Science
- Medical diagnosis (e.g. Lab on a Chip
(LOC))
- Medical applications (e.g. drug delivery)
- Chemical sensors
- Filters for water and food treatment
Electronics & ICT
- Lighting elements, CNT based field
emission displays
- Microelectronic: Single electron
transistor
- Molecular computing and data storage
- Ultra-sensitive electromechanical sensors
- Micro-Electro-Mechanical Systems
(MEMS)
Energy
- Hydrogen storage, energy storage (super
capacitors)
- Solar cells
- Fuel cells
- Superconductive materials

30. Carbon nanotubes
 Have raised concerns due to a superficial likeness to
asbestos fibres and extreme durability
 Potential exposures during manufacturing,
processing, product use and disposal
 Have been researched more than most manufactured
nanostructures

31. CNT Research
 Results have been variable dependent on dose, testing model, purity and type
of nanostructure
 Research results to date:
 Some coated CNTs appear to move freely throughout the body (mice) whereas others
are rapidly excreted
 Installation experiments have shown inflammatory, fibrotic and immune changes
 Inhalation experiments have shown small changes in the lung
 Effects on the immune system
 Effects on cell growth and death
 Modification of tube coating by aquatic organisms

32. IOM HARN Report
 Funded by Defra
 Objective – "to undertake a scoping
study to review the existing literature
on industrial fibres and HARN to
determine whether high aspect ratio
nanoparticles (HARN) should raise the
same concerns as do asbestos fibres"
 "This review has identified many
similarities between HARN and
asbestos with regard to their physico-
chemical properties and toxicological
effects and has concluded that there is
sufficient evidence to suggest that
HARN which have the same
characteristics (diameter, length and
biopersitence) as pathogenic fibres are
likely to have similar pathology.
This review has also highlighted the
lack of data in key areas of toxicology,
exposure and assessment."

33. Regulation
 New generic nanotechnology regulations would be difficult to devise.
 More likely that current regulations/legislation will be adapted to take
account of developments at the nanoscale.
 Review by the European Commission* on the regulatory aspects of
nanotechnology : chemicals (REACH), worker protection (e.g. Directive
89/391/EEC), products (e.g. General Product Safety Directive),
environmental protection (e.g. Directive 2006/12/EC on waste)
 "Current legislation covers in principle the potential health, safety and
environmental risks in relation to nanomaterials ...."
*Regulatory Aspects of Nanomaterials – Communication from the European Commission 2008

34. REACH
 Regulation (EC) No 1907/2006 of the European Parliament and of the Council
on the Registration, Evaluation, Authorisation and Restriction of Chemicals
 "REACH is based on the principle that manufacturers, importers and
downstream users have to ensure that they manufacture, place on the market
or use such substances that do not adversely affect human health or the
environment."
 Places an obligation on importers/manufacturers to produce a registration
dossier for any substance that is imported/manufactured in a quantity greater
than 1 tonne (>10 tonnes – chemical safety report)
 Commission report states "There are no provisions in REACH referring
explicitly to nanomaterials. However, nanomaterials are covered by the
“substance” definition in REACH."

35. REACH and nanomaterials
 Registration document will need to be updated if a
nanoversion of a material is introduced
 however novel nanomaterials may not reach the weight threshold for
notification
 Current testing guidelines may need to be modified – in the
interim testing should be carried out according to existing
guidelines
 Substances of high concern require special authorisation
 effects of most nanomaterials are unknown

36. October 2008
 Amendment (Commission Regulation (EC) No 987/2008)
concerning the removal of carbon and graphite from lists of
exempt materials:
 "The review carried out by the Commission pursuant to
Article 138(4) has revealed that three substances listed in
Annex IV should be removed from that Annex, as
insufficient information is known about these substances
for them to be considered as causing minimum risk
because of their intrinsic properties ... This is also the case
with carbon and graphite, in particular due to the fact that
the concerned Einecs and/or CAS numbers are used to
identify forms of carbon or graphite at the nano-scale,
which do not meet the criteria for inclusion in this Annex."

37. Nanotechnology and product liability
1. New technology and the concept of "defect"
2. Development risks
what is "discoverable"?
emerging knowledge and the benefit of hindsight

38. Nanotechnology and product liability
 Regulatory intervention and regulatory compliance
 Implications of REACH-style regulation
 Relative responsibilities
• innovators
• other suppliers
• regulators
 Duties to research/test/investigate/inquire